PLUVICTO
In PSMA+ mHSPC* (with hormone therapy)
and mCRPC (after hormone therapy)†
Victory
looks
like this
Patient portrayal.
Now FDA approved as early as
metastatic prostate cancer diagnosis1
PLUVICTO
In PSMA+ mHSPC* (with hormone therapy)
and mCRPC (after hormone therapy)†
Now FDA approved as early as
Victory
looks
like this
Patient portrayal.
metastatic prostate cancer diagnosis1